Greg Wiseman
Impact in
- Family Practice top 10%
- Medication Adherence and Compliance
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation 1
- Genetics 2
- Inflammatory Bowel Disease 2
- Co-authors
- Leo I. Gordon (2 shared papers)Mohamed Darif (2 shared papers)Christos E. Emmanouilides (2 shared papers)Thomas Elmer Witzig (2 shared papers)Arturo Molina (2 shared papers)Russell J. Schilder (1 shared paper)Christine A. White (1 shared paper)Adam Robinson (1 shared paper)
- Journals
- Blood (1 paper)BMJ Open (1 paper)Gut (1 paper)European Journal of Cancer (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Greg Wiseman
9 papers receiving 760 citations
Peers
Comparison fields: 5 of 38
- Family Practice 21
- Radiology, Nuclear Medicine and Imaging 175
- Oncology 151
- Pathology and Forensic Medicine 93
- Hepatology 23
Countries citing papers authored by Greg Wiseman
This map shows the geographic impact of Greg Wiseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Wiseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Wiseman more than expected).
Fields of papers citing papers by Greg Wiseman
This network shows the impact of papers produced by Greg Wiseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Wiseman. The network helps show where Greg Wiseman may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Wiseman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. | 2003 | 397 |
| 2 | 2004 | 152 | |
| 3 | 2004 | 97 | |
| 4 | 2013 | 67 | |
| 5 | 2013 | 38 | |
| 6 | Radiation exposure is very low to patient family members following Zevalin yttrium-90 anti-CD20 monoclonal antibody therapy for lymphoma | 2001 | 22 |
| 7 | 2022 | 4 | |
| 8 | Management of Pediatric Thoracic Empyema in the North Queensland Region of Australia and Impact of a Local Evidence-based Treatment Guideline | 2022 | 3 |
| 9 | 2014 | 1 |
About Greg Wiseman
Greg Wiseman is a scholar working on Critical Care and Intensive Care Medicine, Genetics, Hepatology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 9 papers that have together received 781 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (2 papers), Pleural and Pulmonary Diseases (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Peptidase Inhibition and Analysis (1 paper), Trauma, Hemostasis, Coagulopathy, Resuscitation (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Family Practice (21 citations), Radiology, Nuclear Medicine and Imaging (175 citations), Oncology (151 citations), Pathology and Forensic Medicine (93 citations) and Hepatology (23 citations). Greg Wiseman has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Leo I. Gordon, Mohamed Darif, Christos E. Emmanouilides, Thomas Elmer Witzig, Arturo Molina, Russell J. Schilder, Christine A. White, Adam Robinson, Matthew C. Hankins and Michael Jones. Their work appears in journals such as Blood, BMJ Open, Gut, European Journal of Cancer and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.